District Court, W.D. Washington, 2021

Craig v. Novartis Pharmaceuticals Corporation

Craig v. Novartis Pharmaceuticals Corporation
District Court, W.D. Washington · Decided July 22, 2021
Craig v. Novartis Pharmaceuticals Corporation

Trial Court Opinion

UNITED STATES DISTRICT COURT 3 WESTERN DISTRICT OF WASHINGTON AT SEATTLE DEBRA CRAIG, Plaintiff, v. C20-1641 TSZ NOVARTIS PHARMACEUTICALS MINUTE ORDER CORPORATION, 9 Defendant.

The following Minute Order is made by direction of the Court, the Honorable Thomas S. Zilly, United States District Judge: (1) Plaintiff Debra Craig’s motion to stay, docket no. 27, is GRANTED. All proceedings in this action are STAYED until further order of this Court. Although neither party compellingly argues that it will suffer prejudice, hardship, or inequity if the proceedings are or are not stayed, the Court finds judicial economy and efficiency heavily weigh in favor of a stay. See Rivers v. Walt Disney, 980 F. Supp. 1358, 1360–62 (C.D. 14 Cal. 1997) (“[I]t appears that a majority of courts have concluded that it is often appropriate to stay preliminary pretrial proceedings while a motion to transfer and consolidate is pending with the [Multidistrict Litigation] Panel because of the judicial resources that are conserved.”); (2) The parties are DIRECTED to promptly notify the Court of the Judicial Panel on Multidistrict Litigation’s ruling on Plaintiff’s pending motion to transfer this action; and (3) The Clerk is directed to send a copy of this Minute Order to all counsel of record.

20 Dated this 22nd day of July, 2021.

Ravi Subramanian 22 Clerk

Case-law data current through December 31, 2025. Source: CourtListener bulk data.